Suven Life Sciences gets patents for neurological drug
Archive for category: Intellectual Property Rights
Suven Life’s NCEs for neurodegenerative diseases receive European & Hong Kong patents – Courtesy(Pharmabiz.com)
Pharma Live, , Intellectual Property Rights, 0Suven Life Sciences Ltd (Suven), a Hyderabad-based biopharmaceutical company focussed on discovering, developing and commercialising novel pharmaceutical products, has...
Sanders Asks VA to Break Patents on Gilead and AbbVie Hep C Drugs – Courtesy(Pharmalot)
Pharma Live, , Intellectual Property Rights, 0The ongoing debate over the cost of prescription drugs took another twist as U.S. Sen. Bernie Sanders (I-VT.) has...
Drug patents are Bad for your health: the cost of mismarketing – By Dean Baker
Pharma Live, , Intellectual Property Rights, 0The rationale for granting patents for new drugs is to give companies incentives to research new and better drugs....
Last fall, India’s new Prime Minister, Narendra Modi, met with President Obama in Washington. According to the public accounts,...
Louisiana Challenge’s AstraZeneca on Antitrust Claims for Asserting Invalid Drug Patents – Courtesy(PATENTLYO)
Pharma Live, , Intellectual Property Rights, 0In March 2015, the state of Louisiana filed suit against AstraZeneca alleging antitrust violations based upon the company’s actions of...
Patent office rejects J&J arm’s plea for HIV drug intermediate – Courtesy (Financial Express)
Pharma Live, , Intellectual Property Rights, 0In a setback to US consumer health behemoth Johnson & Johnson, India’s patent office has rejected an application from...
Drug Patents: A New Hedge Fund Target – Courtesy ( Seeking Alpha.com)
Pharma Live, , Intellectual Property Rights, 0Summary Hedge funds managers are attacking what they see as “weak patents” held by pharmaceutical companies while they are...
Biogen Inc (BIIB) May Soon Trump Pfizer In Global CNS Drug Sales – Courtesy(bidnessetc.com)
Pharma Live, , Intellectual Property Rights, 0Pfizer Inc. (NYSE:PFE), presently the world’s largest seller of central nervous system (CNS) drugs, may have its future lead...
It’s not just big pharma that wants to see IPR reform in US patent legislation – By Richard Lloyd
Pharma Live, , Intellectual Property Rights, 0For over an hour yesterday, as the Senate Judiciary Committee hearing on the recently introduced PATENT Act unfolded, it seemed like we were...